Skip to main content

Table 4 Multivariate Survival Analysis According To Clinical and Laboratory Parameters.

From: Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Variable

Hazard Ratio

IC 95% Hazard ratio

P

Liver Disease (yes vs no)

1.68

1.025–2.75

0.04

LDH (high vs normal)

1.89

1.17–3.06

0.009

Fibrinogen (high vs normal)

1.99

1.24–3.19

0.004

  1. Evaluated 129 pts (parameters considered: PS, liver disease, lymphocytes, LDH, ESR, PCR, Fibrinogen and WBC)